Gene · 55244
Papers1,509
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,509
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Precision medication based on the evaluation of drug metabolizing enzyme and transporter functions. | Precis Clin Med | 2025 | 40110576 | PubTator, text mining | PubMed |
| STANCE: a unified statistical model to detect cell-type-specific spatially variable genes in spatial transcriptomics. | Nat Commun | 2025 | 39979358 | PubTator, text mining | PubMed |
| Drug transporter mRNA expression and genital inflammation in South African women on oral pre-exposure prophylaxis (PrEP). | AIDS Res Ther | 2025 | 39955595 | PubTator, text mining | PubMed |
| Potential Interaction of Pinocembrin with Drug Transporters and Hepatic Drug-Metabolizing Enzymes. | Pharmaceuticals (Basel) | 2025 | 39861105 | PubTator, text mining | PubMed |
| Proximal tubule-on-chip as a model for predicting cation transport and drug transporter dynamics. | Sci Rep | 2025 | 39833212 | PubTator, text mining | PubMed |
| MDMA pharmacokinetics: A population and physiologically based pharmacokinetics model-informed analysis. | CPT Pharmacometrics Syst Pharmacol | 2025 | 39592887 | PubTator, text mining | PubMed |
| New Biomarkers for Renal Transporter-Mediated Drug-Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in Humans. | Clin Pharmacol Ther | 2025 | 39148267 | PubTator, text mining | PubMed |
| Lung cancer, platinum analog-based frontline treatment and pharmacogenetic limitations. | Per Med | 2024 | 39560009 | PubTator, text mining | PubMed |
| Allele frequencies and genotype distribution of three metformin transporter polymorphisms in Mexican population and their application in pharmacogenomics of type 2 diabetes. | Front Pharmacol | 2024 | 39555090 | PubTator, text mining | PubMed |
| Reply to Comment on "Brief Report: Tyrosine Kinase Inhibitors for Lung Cancers That Inhibit MATE-1 Can Lead to 'False' Decreases in Renal Function". | J Thorac Oncol | 2024 | 39510707 | PubTator, text mining | PubMed |
| Comment on "Brief Report: Tyrosine Kinase Inhibitors for Lung Cancers That Inhibit MATE-1 Can Lead to 'False' Decreases in Renal Function". | J Thorac Oncol | 2024 | 39510706 | PubTator, text mining | PubMed |
| Prediction of Inhibitory Activity against the MATE1 Transporter via Combined Fingerprint- and Physics-Based Machine Learning Models. | J Chem Inf Model | 2024 | 39254593 | PubTator, text mining | PubMed |
| Pharmacokinetic Simulation and Area under the Curve Estimation of Drugs Subject to Enterohepatic Circulation. | Pharmaceutics | 2024 | 39204389 | PubTator, text mining | PubMed |
| DkDTX1/MATE1 mediates the accumulation of proanthocyanidin and affects astringency in persimmon. | Plant Cell Environ | 2024 | 39169830 | PubTator, text mining | PubMed |
| The role of genetic variants in the prediction of hearing loss due to cisplatin chemoradiotherapy. | Cancer Med | 2024 | 39159054 | PubTator, text mining | PubMed |
| Dysregulation of Human Hepatic Drug Transporters by Proinflammatory Cytokines. | J Pharmacol Exp Ther | 2024 | 39103232 | PubTator, text mining | PubMed |
Interactions of bosutinib with drug transporters: In vitro and In vivo inhibition of organic cation transporter 2, multidrug and toxin extrusion protein 1, and breast cancer resistance protein by bosutinib. | Biomed Pharmacother | 2024 | 39053425 | PubTator, text mining | PubMed |
| Evaluation of arsenic phytoremediation potential in Azolla filiculoides Lam. plants under low pH stress conditions. | Plant Physiol Biochem | 2024 | 39053312 | PubTator, text mining | PubMed |
| Pseudo-Worsening of Kidney Function Due to Inhibition of Renal Creatinine Secretion: Quality of Information Provided in Prescribing Information/SmPC. | Clin Pharmacol Ther | 2024 | 38989645 | PubTator, text mining | PubMed |
| Association of Genetic Polymorphism rs 77630697(Gly64Asp) of Multidrug and Toxin Extrusion -1 with glycemic response to metformin in patients with Type 2 Diabetes Mellitus. | Pak J Med Sci | 2024 | 38952525 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55244/papers?page=4